American Research & Management Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.67M | Buy |
19,376
+41
| +0.2% | +$3.66K | 0.46% | 55 |
|
|
2022
Q2 | $1.76M | Buy |
19,335
+250
| +1% | +$22.2K | 0.45% | 57 |
|
|
2022
Q1 | $1.57M | Sell |
19,085
-461
| -2% | -$36.3K | 0.35% | 63 |
|
|
2021
Q4 | $1.5M | Buy |
19,546
+325
| +2% | +$25.9K | 0.32% | 63 |
|
|
2021
Q3 | $1.44M | Sell |
19,221
-350
| -2% | -$26.6K | 0.33% | 62 |
|
|
2021
Q2 | $1.52M | Sell |
19,571
-6,231
| -24% | -$463K | 0.35% | 59 |
|
|
2021
Q1 | $1.9M | Sell |
25,802
-1,077
| -4% | -$79.4K | 0.46% | 53 |
|
|
2020
Q4 | $2.1M | Buy |
26,879
+2,062
| +8% | +$158K | 0.55% | 49 |
|
|
2020
Q3 | $1.96M | Sell |
24,817
-356
| -1% | -$27.9K | 0.57% | 48 |
|
|
2020
Q2 | $1.86M | Sell |
25,173
-131
| -0.5% | -$9.86K | 0.56% | 47 |
|
|
2020
Q1 | $1.86M | Sell |
25,304
-367
| -1% | -$28.8K | 0.71% | 44 |
|
|
2019
Q4 | $2.23M | Sell |
25,671
-314
| -1% | -$25.8K | 0.66% | 45 |
|
|
2019
Q3 | $2.09M | Sell |
25,985
-2,044
| -7% | -$164K | 0.63% | 44 |
|
|
2019
Q2 | $2.24M | Sell |
28,029
-398
| -1% | -$30.5K | 0.67% | 42 |
|
|
2019
Q1 | $2.26M | Sell |
28,427
-52
| -0.2% | -$3.89K | 0.64% | 40 |
|
|
2018
Q4 | $2.08M | Sell |
28,479
-944
| -3% | -$66.6K | 0.7% | 41 |
|
|
2018
Q3 | $1.99M | Sell |
29,423
-1,106
| -4% | -$70.5K | 0.59% | 48 |
|
|
2018
Q2 | $1.77M | Sell |
30,529
-2,381
| -7% | -$134K | 0.61% | 43 |
|
|
2018
Q1 | $1.71M | Sell |
32,910
-4,637
| -12% | -$250K | 0.56% | 45 |
|
|
2017
Q4 | $2.02M | Sell |
37,547
-1,969
| -5% | -$109K | 0.62% | 44 |
|
|
2017
Q3 | $2.41M | Sell |
39,516
-572
| -1% | -$34.7K | 0.78% | 41 |
|
|
2017
Q2 | $2.45M | Sell |
40,088
-520
| -1% | -$31.7K | 0.81% | 38 |
|
|
2017
Q1 | $2.46M | Sell |
40,608
-2,470
| -6% | -$150K | 0.88% | 34 |
|
|
2016
Q4 | $2.42M | Sell |
43,078
-625
| -1% | -$36.6K | 0.83% | 37 |
|
|
2016
Q3 | $2.6M | Sell |
43,703
-220
| -0.5% | -$12.9K | 0.95% | 33 |
|
|
2016
Q2 | $2.41M | Sell |
43,923
-3,087
| -7% | -$164K | 0.93% | 35 |
|
|
2016
Q1 | $2.37M | Sell |
47,010
-624
| -1% | -$30.6K | 1% | 33 |
|
|
2015
Q4 | $2.4M | Sell |
47,634
-2,150
| -4% | -$108K | 1.03% | 32 |
|
|
2015
Q3 | $2.35M | Sell |
49,784
-2,210
| -4% | -$117K | 1.03% | 32 |
|
|
2015
Q2 | $2.82M | Sell |
51,994
-413
| -0.8% | -$23.2K | 1.15% | 29 |
|
|
2015
Q1 | $2.87M | Sell |
52,407
-152
| -0.3% | -$8.61K | 1.17% | 29 |
|
|
2014
Q4 | $2.85M | Sell |
52,559
-100
| -0.2% | -$5.57K | 1.05% | 31 |
|
|
2014
Q3 | $2.98M | Buy |
52,659
+356
| +0.7% | +$20K | 1.07% | 33 |
|
|
2014
Q2 | $2.89M | Sell |
52,303
-99
| -0.2% | -$5.4K | 1% | 34 |
|
|
2014
Q1 | $2.84M | Sell |
52,402
-368
| -0.7% | -$19.1K | 1.01% | 34 |
|
|
2013
Q4 | $2.52M | Buy |
52,770
+146
| +0.3% | +$6.67K | 0.9% | 37 |
|
|
2013
Q3 | $2.39M | Sell |
52,624
-910
| -2% | -$41.5K | 0.95% | 35 |
|
|
2013
Q2 | $2.37M | Buy |
+53,534
| New | +$2.39M | 0.95% | 35 |
|
Other funds holding MRK
American Research & Management Company's MRK Position: Q3 2022 in Review
American Research & Management Company increased its Merck (MRK) stake by 0.21% in Q3 2022, buying an estimated $3.66K and bringing the position to 19,376 shares worth $1.67M. The position accounts for 0.46% of the portfolio, ranked #55.
American Research & Management Company first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $2.98M in Q3 2014. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- American Research & Management Company held 19,376 shares of Merck worth $1.67M as of Q3 2022.
- American Research & Management Company bought 41 Merck shares in Q3 2022, an estimated $3.66K.
- Merck made up 0.46% of American Research & Management Company's portfolio in Q3 2022, its #55 holding.
- American Research & Management Company first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's Merck position peaked at $2.98M in Q3 2014.
- 2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.